EUROMEDIX: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
EUROMEDIX
Largest movements
No asset line moved by more than 1% of the balance sheet total.
- Other debts -€49,819
down €49,819 (-24.8%), from €200,957 to €151,139
- Trade debts +€35,135
up €35,135 (+1,132%), from €3,104 to €38,240
- Provisions +€20,000
new in 2025: €20,000
- Gross operating margin +€23,121
up €23,121 (+225%), from €10,277 to €33,398
- Provisions +€20,000
new in 2025: €20,000
- Other operating charges +€6,877
up €6,877 (+196%), from €3,507 to €10,384
- Taxes -€429
no longer reported in 2025 (was €429)
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €1,199,047 | €1,203,364 | +€4,317 | +0.4% |
| Fixed assets | 21/28 | €1,056,200 | €1,053,311 | -€2,889 | -0.3% |
| Tangible fixed assets | 22/27 | €1,056,107 | €1,053,218 | -€2,889 | -0.3% |
| Land and buildings | 22 | €1,056,107 | €1,053,218 | -€2,889 | -0.3% |
| Financial fixed assets | 28 | €93 | €93 | = | 0.0% |
| Current assets | 29/58 | €142,847 | €150,053 | +€7,206 | +5.0% |
| Amounts receivable within one year | 40/41 | €142,029 | €149,013 | +€6,984 | +4.9% |
| Trade receivables | 40 | €140,818 | €140,818 | = | 0.0% |
| Other amounts receivable | 41 | €1,210 | €8,194 | +€6,984 | +577% |
| Cash at bank and in hand | 54/58 | €152 | €326 | +€175 | +115% |
| Deferred charges and accrued income | 490/1 | €667 | €714 | +€47 | +7.1% |
| Total equity and liabilities | 10/49 | €1,199,047 | €1,203,364 | +€4,317 | +0.4% |
| Equity | 10/15 | €982,002 | €981,658 | -€344 | 0.0% |
| Contributions | 10/11 | €62,000 | €62,000 | = | 0.0% |
| Capital | 10 | €62,000 | €62,000 | = | 0.0% |
| Issued capital | 100 | €62,000 | €62,000 | = | 0.0% |
| Revaluation surpluses | 12 | €779,624 | €779,624 | = | 0.0% |
| Reserves | 13 | €132,061 | €131,717 | -€344 | -0.3% |
| Non-distributable reserves | 130/1 | €6,200 | €6,200 | = | 0.0% |
| Legal reserve | 130 | €6,200 | €6,200 | = | 0.0% |
| Distributable reserves | 133 | €125,861 | €125,517 | -€344 | -0.3% |
| Profit (loss) carried forward | 14 | €8,317 | €8,317 | = | 0.0% |
| Provisions and deferred taxes | 16 | - | €20,000 | +€20,000 | |
| Provisions for liabilities and charges | 160/5 | - | €20,000 | +€20,000 | |
| Other liabilities and charges | 164/5 | - | €20,000 | +€20,000 | |
| Amounts payable | 17/49 | €217,045 | €201,706 | -€15,339 | -7.1% |
| Amounts payable within one year | 42/48 | €217,045 | €201,706 | -€15,339 | -7.1% |
| Financial debts | 43 | €4,150 | €4,150 | = | 0.0% |
| Credit institutions | 430/8 | €4,150 | €4,150 | = | 0.0% |
| Trade debts | 44 | €3,104 | €38,240 | +€35,135 | +1,132% |
| Suppliers | 440/4 | €3,104 | €38,240 | +€35,135 | +1,132% |
| Taxes, remuneration and social security | 45 | €8,834 | €8,178 | -€656 | -7.4% |
| Taxes | 450/3 | €8,693 | €8,038 | -€656 | -7.5% |
| Remuneration and social security | 454/9 | €140 | €140 | = | 0.0% |
| Other amounts payable | 47/48 | €200,957 | €151,139 | -€49,819 | -24.8% |
| Remuneration, social security and pensions | 62 | €258 | - | -€258 | |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €2,888 | €2,889 | +€1 | 0.0% |
| Provisions for liabilities and charges: additions (uses and reversals) | 635/8 | - | €20,000 | +€20,000 | |
| Other operating charges | 640/8 | €3,507 | €10,384 | +€6,877 | +196% |
| Gross operating margin | 9900 | €10,277 | €33,398 | +€23,121 | +225% |
| Operating profit (loss) | 9901 | €3,626 | €125 | -€3,500 | -96.5% |
| Financial income | 75/76B | €119 | - | -€119 | |
| Recurring financial income | 75 | €119 | - | -€119 | |
| Financial charges | 65/66B | €389 | €470 | +€81 | +20.8% |
| Recurring financial charges | 65 | €389 | €470 | +€81 | +20.8% |
| Profit (loss) for the period before taxes | 9903 | €3,356 | -€344 | -€3,701 | |
| Income taxes | 67/77 | €429 | - | -€429 | |
| Profit (loss) for the period | 9904 | €2,927 | -€344 | -€3,272 | |
| Profit (loss) for the period to be appropriated | 9905 | €2,927 | -€344 | -€3,272 |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 23 October 2026 via checked.be.